Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)
一项双盲、比较、随机的日本试验研究方案，旨在评估三联标准止吐疗法联合或不联合 5 mg 奥氮平治疗，以预防接受蒽环类/环磷酰胺方案治疗的乳腺癌患者化疗引起的恶心和呕吐（JTOP-B）。
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2021-058755
Ozeki, Rie; Iihara, Hirotoshi; Shimokawa, Mototsugu; Hashimoto, Hironobu; Abe, Masakazu; Mukohara, Toru; Bando, Hiroko; Hayashi, Toshinobu; Kawazoe, Hitoshi; Komoda, Masayo; Yanai Takahashi, Takako; Saito, Mitsue
